GE HealthCare Technologies Inc. (GEHC)
(Delayed Data from NSDQ)
$90.25 USD
-0.52 (-0.57%)
Updated Oct 10, 2024 04:00 PM ET
After-Market: $90.25 0.00 (0.00%) 4:42 PM ET
3-Hold of 5 3
B Value D Growth C Momentum C VGM
Price, Consensus and EPS Surprise
GEHC 90.25 -0.52(-0.57%)
Will GEHC be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for GEHC based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for GEHC
GEHC's MIM Software to Aid Radiation Therapy With Its Latest FDA Nod
InspireMD Gains FDA Premarket Approval for CGuard Prime Carotid Stent
GEHC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Reasons to Retain GE HealthCare Stock in Your Portfolio Now
GE HealthCare Stock Likely to Rise After FDA Approval of Flyrcado
GE HealthCare Shares Rise After AI-Powered Venue Sprint's Launch
Other News for GEHC
Jim Cramer Likes Reddit Very Much, Calls Accenture A 'Great Buy'
GE HealthCare takes role in consortium for cancer care for patients in Europe
Buy Rating for GE Healthcare Technologies Inc. on Flyrcado’s Market Disruption Potential
GE HealthCare completes manganese-based MRI clinical development program
GE Hlthcare Tech Inc put volume heavy and directionally bearish